Loading...
Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with limited treatment options. Chimeric antigen receptor T cells (CAR‐T) are genetically engineered T cells that can specifically kill tumor cells without major histocompatibility complex restriction. Encouraging progress in CAR‐T...
Na minha lista:
| Udgivet i: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718528/ https://ncbi.nlm.nih.gov/pubmed/31339230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2430 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|